USTEKINUMAB

ustekinumab 90 mg/mL injection, 1 mL syringe

USTEKINUMAB (14943L)

ustekinumab 90 mg/mL injection, 1 mL syringe
14943L
Body System:
Manner of administration:Injection
General Schedule
Authority Required

Restriction

Indication: Severe chronic plaque psoriasis
Treatment phase: First continuing treatment (Whole body) - treatment covering week 28 and onwards

Restriction

Indication: Severe chronic plaque psoriasis
Treatment phase: First continuing treatment (Face, hand, foot) - treatment covering week 28 and onwards
Quantities & Cost
Max qty packs Max qty units # of repeats DPMQ Max safety net General Patient Charge
Max qty packs: 1 Max qty units: 1 # of repeats: 1 DPMQ: $1,002.28 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
Steqeyma